Patients have always been at the heart of everything we do.
References
[1]
Palladini G, Merlini G. What is new in diagnosis and management of light chain amyloidosis? Blood. 2016;128(2):159-168. https://doi.org/10.1182/blood-2016-01-629790 PMid:27053535
[2]
Myeloma UK AL amyloidosis Essential Guide. Accessed May 30, 2022.
[3]
Merlini G, Palladini G. Light chain amyloidosis: the heart of the problem. Haematologica. 2013;98(10):1492.
[4]
NHS. Amyloidosis. Accessed May 26, 2022.
[5]
McCausland KL, White MK, Guthrie SD, et al. Light chain (AL) amyloidosis: the journey to diagnosis. The Patient-Patient-Centered Outcomes Research. 2018;11(2):207-16.
[6]
Stanford Health Care. AL (Primary) Amyloidosis. Accessed May 26, 2022.
[7]
John Hopkins Medicine. What is amyloidosis?. Accessed May 26, 2022.
[8]
Amyloidosis Foundation. AA Amyloidosis. Accessed May 26, 2022.
[9]
Amyloidosis Foundation. Hereditary Amyloidosis. Accessed May 26, 2022.
[10]
Amyloidosis Foundation. Wild-type Amyloidosis. Accessed May 26, 2022.
[11]
Mayo Clinic. Amyloidosis. Accessed May 26, 2022.
[12]
Myeloma UK. AL amyloidosis. Accessed May 26, 2022.
[13]
Merlini G, Dispenzieri A, Sanchorawala V, et al. Systematic immunglobulin light chain amyloidosis. Nature Review Disease Primers. 2018;4(1):38.
[14]
Bahlis NJ, Lazarus HM. Multiple myeloma-associated AL amyloidosis. Bone Marrow Transplantation. 2006;38;7-15.